BDBM652125 6-chloro-N-(1-{3-[(3,3- difluoroazetidin-1- yl)methyl]bicyclo[1.1.1]pentan-1- yl}-1H-pyrazol-4-yl)-7-[1-(3- methyloxetan-3-yl)piperidin-4- yl]quinazolin-2-amine::US12540131, Ex-2.60

SMILES CC1(N2CCC(c3cc4nc(Nc5cnn(C67CC(CN8CC(F)(F)C8)(C6)C7)c5)ncc4cc3Cl)CC2)COC1

InChI Key InChIKey=HRJIDYHZALQGJH-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 652125   

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 652125BDBM652125(6-chloro-N-(1-{3-[(3,3- difluoroazetidin-1- yl)met...)
Affinity DataIC50: 0.631nMAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/15/2026
Entry Details
US Patent